← SynDRA
GSK-356278
SynDRA canonical compound SYN0039540 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | PDE4A | PDE4B | PDE4C | PDE4D |
| Mechanism of action | phosphodiesterase inhibitor |
All known targets
Mechanisms of action (all sources)
- phosphodiesterase inhibitor
- PDE4D INHIBITOR
- PDE4B INHIBITOR
- PDE4A INHIBITOR
Cross-references
Synonyms
- GSK356278
- GSK356278B
- PDE4 inhibitor (oral, depression/anxiety), GlaxoSmithKline
- 1QTA9P992C
- RefChem:144522
- DTXCID00144892
- MFCD27987927
- UNII-1QTA9P992C
- orb1305078
- SCHEMBL2412775
- SCHEMBL29392139
- C21H25N7O2S
- GLXC-04811
- EX-A11252
- AKOS027338707
- SB16753
- DA-38123
- MS-27895
- HY-106003
- CS-0024611
- NS00072268
- T27475
Look up GSK-356278 in the interactive SynDRA portal →